​

Aquestive Therapeutics Ownership | Who Owns Aquestive Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Aquestive Therapeutics Ownership Summary

Aquestive Therapeutics is owned by 66.26% institutional investors, 4.02% insiders, and 29.71% retail investors. Bratton capital management is the largest institutional shareholder, holding 9.88% of AQST shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.43% of its assets in Aquestive Therapeutics shares.

AQST Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAquestive Therapeutics66.26%4.02%29.71%
SectorHealthcare Stocks 42.50%10.81%46.69%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.16%11.89%61.94%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bratton capital management9.81M9.88%$54.84M
Blackrock5.45M7.41%$14.18M
Blackrock funding, inc. /de6.53M6.57%$36.48M
Rtw investments, lp6.25M6.29%$34.94M
Vanguard group5.66M5.70%$31.65M
Perceptive advisors3.76M3.79%$21.02M
Ecor1 capital2.63M2.64%$14.67M
Samsara biocapital2.50M2.52%$13.97M
Geode capital management2.09M2.10%$11.67M
State street1.60M1.61%$8.96M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bratton capital management9.81M100.00%$54.84M
Blue owl capital lp1.25M2.17%$6.99M
Sio capital management1.50M2.12%$8.37M
Samsara biocapital2.50M1.82%$13.97M
Everstar asset management368.29K1.17%$2.06M
Latash investments243.13K0.99%$1.36M
Dafna capital management512.59K0.71%$2.87M
Ecor1 capital2.63M0.70%$14.67M
Perceptive advisors3.76M0.61%$21.02M
Stonepine capital management100.60K0.46%$562.35K

Top Buyers

HolderShares% AssetsChange
Rtw investments, lp6.25M0.43%6.25M
Blackrock5.45M0.00%4.11M
Ecor1 capital2.63M0.70%2.63M
Samsara biocapital2.50M1.82%2.50M
Perceptive advisors3.76M0.61%1.57M

Top Sellers

HolderShares% AssetsChange
Vr adviser---2.63M
Franklin resources---2.13M
Bioimpact capital---1.61M
Pale fire capital se93.13K0.06%-1.58M
Laurion capital management lp---1.55M

New Positions

HolderShares% AssetsChangeValue
Rtw investments, lp6.25M0.43%6.25M$34.94M
Ecor1 capital2.63M0.70%2.63M$14.67M
Samsara biocapital2.50M1.82%2.50M$13.97M
Commonwealth equity services1.06M0.01%1.06M$5.92M
Federated hermes783.78K0.01%783.78K$4.38M

Sold Out

HolderChange
National bank of canada /fi/-4.00
Ifp advisors-10.00
Coppell advisory solutions-16.00
Highmark wealth management-50.00
Lindbrook capital-109.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202515036.36%65,817,25445.31%663.19%9848.48%2833.33%
Jun 30, 2025118-5.60%47,569,6177.50%472.23%66-9.59%26-13.33%
Mar 31, 20251255.93%44,252,8622.02%462.04%738.96%30-6.25%
Dec 31, 2024117-4.10%43,374,494-7.27%471.81%66-15.38%3233.33%
Sep 30, 202412223.23%46,774,77210.17%511.54%7931.67%23-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.40M2.43%-
Vanguard Total Stock Mkt Idx Inv2.35M2.37%-52.26K
iShares Russell 2000 ETF2.09M1.73%-
Fidelity Small Cap Index861.98K0.87%108.98K
Vanguard Institutional Extnd Mkt Idx Tr855.73K0.86%-400.11K
Invesco Dorsey Wright SmallCap Momt ETF775.69K0.85%1.41K
Nuveen Equity Index R6649.35K0.71%-
Franklin Biotechnology Discv A(acc)USD521.70K0.57%-821.40K
MEDICAL BioHealth EUR Acc485.29K0.53%-
State St Russell Sm/Mid Cp® Indx NL Cl C412.88K0.42%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 15, 2025Jung Cassie Chief Operating OfficerSell$473.70K
Oct 15, 2025Kraus Carl N Chief Medical OfficerSell$141.90K
Oct 15, 2025Boyd Peter E. See RemarksSell$70.00K
Sep 26, 2025Barber Daniel President and CEOSell$551.19K
Sep 26, 2025Boyd Peter E. See RemarksSell$63.00K

Insider Transactions Trends

DateBuySell
2025 Q4-3
2025 Q3-5
2025 Q2--
2025 Q1--
2024 Q4-1

AQST Ownership FAQ

Who Owns Aquestive Therapeutics?

Aquestive Therapeutics shareholders are primarily institutional investors at 66.26%, followed by 4.02% insiders and 29.72% retail investors. The average institutional ownership in Aquestive Therapeutics's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.16%, which Aquestive Therapeutics exceeds.

Who owns the most shares of Aquestive Therapeutics?

Aquestive Therapeutics’s largest shareholders are Bratton capital management (9.81M shares, 9.88%), Blackrock (5.45M shares, 7.41%), and Blackrock funding, inc. /de (6.53M shares, 6.57%). Together, they hold 23.86% of Aquestive Therapeutics’s total shares outstanding.

Does Blackrock own Aquestive Therapeutics?

Yes, BlackRock owns 7.41% of Aquestive Therapeutics, totaling 5.45M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.18M$. In the last quarter, BlackRock increased its holdings by 4.11M shares, a 305.59% change.

Who is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested?

Bratton capital management is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 9.81M Aquestive Therapeutics shares, valued at 54.84M$.

Who is the top mutual fund holder of Aquestive Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Aquestive Therapeutics shares, with 2.43% of its total shares outstanding invested in 2.4M Aquestive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools